Open Label Extension Study of AMG 531 in Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

This study is enrolling participants by invitation only.

Study NCT00116688 Information provided by Amgen

First Received: June 30, 2005 Last Updated: October 22, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is enrolling participants by invitation only.
Estimated Study Completion Date:	December 2009
Estimated Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)